Published April 2026

Philips CPAP Recall Settlement Update 2026: Where Claims Stand Now

Medically reviewed by licensed healthcare professionals · Legally reviewed by mass tort litigation specialists · Last updated: April 2026

Philips reached a landmark settlement with the U.S. Department of Justice and agreed to pay up to $1.1 billion to resolve personal injury and medical monitoring claims from people harmed by the recalled CPAP, BiPAP, and ventilator devices. Understanding where the claims process stands now and which track applies to you is the critical next step.

Background: Why There Was a Recall

In June 2021, Philips Respironics issued a massive recall of its CPAP, BiPAP, and mechanical ventilator devices — eventually covering approximately 5.5 million devices in the U.S. alone. The recall was triggered by concerns that the polyester-based polyurethane (PE-PUR) foam used for sound abatement in these devices was degrading and releasing foam particles and potentially toxic gases directly into the airway of patients using the devices.

The degraded foam particles, when inhaled or ingested, are composed of materials that include suspected and confirmed carcinogens. The volatile organic compounds (VOCs) off-gassed by degrading foam include diethylene glycol and toluene diisocyanate — chemicals with known toxicity profiles that raise serious cancer and lung disease concerns with long-term exposure.

The Two Settlement Tracks Explained

Personal Injury Track

The personal injury track covers individuals who used recalled Philips devices and subsequently developed qualifying medical conditions. Eligible conditions include various cancers — particularly lung cancer, throat cancer, and nasal/sinus cancer — as well as serious respiratory diseases. This track requires proof of device use (generally through prescription records, device registration, or DME supplier records) and medical documentation of the qualifying diagnosis.

The personal injury track pays based on injury category — more serious diagnoses receive higher compensation tiers. Claimants in this track generally need legal representation to navigate the claims process and ensure their documentation meets the required standards.

Medical Monitoring Track

The medical monitoring track is available to people who used recalled devices but have not yet been diagnosed with a specific qualifying condition. It provides funding for ongoing medical surveillance — regular check-ups, imaging, and tests designed to detect any related health problems at the earliest possible stage. This track is designed for the many device users who were exposed to potential harm but are not yet showing signs of disease.

Medical monitoring is a lower-dollar-value compensation than the personal injury track, but it provides meaningful benefit: professional medical oversight designed to catch problems before they become worse.

Which Devices Are Covered

The recall covered a large number of Philips device models, including the DreamStation CPAP and BiPAP lines, the System One Sleep Therapy System, several BiPAP Advanced and A30 series devices, and various mechanical ventilators used in home and clinical settings. The key identifier is whether your device used the PE-PUR foam in its design — the vast majority of Philips CPAP and BiPAP devices manufactured before the recall did.

Proof of Use Requirements

Both settlement tracks require proof that you actually used a recalled Philips device. The strongest forms of proof are: device registration with Philips (which you may have done when you first received the machine), prescription records from your sleep specialist or primary care physician, records from your durable medical equipment (DME) supplier showing the device was prescribed and delivered to you, and insurance billing records for CPAP supplies associated with the recalled device.

If you used your device for years but don't have formal documentation, a claims attorney can help you identify alternative ways to establish proof of use before deadlines close.

Status of Replacement Devices

Philips offered replacement devices as part of its recall response, but the replacement program has been plagued by delays and inconsistent fulfillment. Receiving a replacement device does not waive your right to pursue a personal injury or medical monitoring claim. The fact that Philips acknowledged the device was defective and offered a replacement is itself evidence relevant to your claim.

What to Do Now

If you used a recalled Philips CPAP or BiPAP device and haven't yet evaluated your claim options, the most important step is contacting an attorney experienced in CPAP recall claims. The claims process has deadlines, documentation requirements, and track-specific eligibility criteria that are easiest to navigate with professional help. A free case evaluation will identify which track applies to you and what documentation you need to gather.